Standard Family Office LLC Neurocrine Biosciences Inc Transaction History

Standard Family Office LLC

  • $82.6 Million
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$75.79 - $100.07 $28,572 - $37,726
377 New
377 $37,000
Q1 2022

May 16, 2022
SELL
$72.45 - $94.81 $38,036 - $49,775
-525 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$79.65 - $106.22 $41,816 - $55,765
525 New
525 $45,000
Q3 2021

Nov 15, 2021
SELL
$86.18 - $99.03 $57,137 - $65,656
-663 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$86.91 - $108.33 $57,621 - $71,822
663 New
663 $64,000

Others Institutions Holding NBIX

# of Institutions
654
Shares Held
96.5M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.4B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Standard Family Office LLC Portfolio

Follow Standard Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Standard Family Office LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email